The CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb have agreed to voluntarily testify at a Senate hearing in February regarding high prescription drug prices in the US, negating the need for a planned subpoena. This decision came following Senator Bernie Sanders’s criticism of the executives for their initial refusal due to claimed lack of expertise.
![](https://healsecurity.com/wp-content/uploads/2024/07/group-ibs-threat-intelligence-and-defence-centre-equip-undergraduates-with-sophisticated.jpg)
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some